MARINUS PHARMACEUTICALS, INC.Nonqualified Stock Option Agreement • November 9th, 2021 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations
Marinus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby grants an option (the “Option”) to purchase shares of its common stock, par value $0.001 (the “Stock”), to the recipient (the “Grantee”) set forth on the Schedule to Nonqualified Stock Option Agreement attached hereto (the “Schedule”), subject to the vesting and other conditions set forth below and in the Schedule. The terms and conditions of the Option are set forth in this Nonqualified Stock Option Agreement and the Schedule (collectively, the “Agreement”), as well as in the Company’s 2014 Equity Incentive Plan (as it may be amended from time to time, the “Plan”). All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.
MARINUS PHARMACEUTICALS, INC.Restricted Stock Unit Agreement • November 9th, 2021 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations
Marinus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby grants restricted Stock Units (the “RSUs”) representing the right to receive shares of its common stock, par value $0.001 (the “Stock”), to the recipient (the “Grantee”) set forth on the Schedule to Restricted Stock Unit Agreement attached hereto (the “Schedule”), subject to the vesting and other conditions set forth below and in the Schedule. The terms and conditions of the RSUs are set forth in this Restricted Stock Unit Agreement and the Schedule (collectively, the “Agreement”), as well as in the Company’s 2014 Equity Incentive Plan (as it may be amended from time to time, the “Plan”). All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.
MARINUS PHARMACEUTICALS, INC.Nonqualified Stock Option Agreement for Non-Employee Directors • November 9th, 2021 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations
this Option will become fully vested and exercisable as of the date of your termination of Service. Term Notwithstanding anything in this Agreement to the contrary, this Option shall expire and you shall immediately and automatically forfeit the Option to the Company in any event at the close of business at Company headquarters on the Expiration Date, as shown on the Schedule. This Option will expire earlier (but never later) if your Service terminates, as described below. Regular Termination If your Service terminates for any reason, other than due to your death or Disability or for Cause, then this Option will expire at the close of business at Company headquarters on the ninetieth (90th) day after your termination date. Termination for Cause If your Service is terminated for Cause, then you shall immediately forfeit all rights to this Option (including to any vested portion of the Option) and the Option shall immediately expire. Death If your Service terminates due to your death, th
MARINUS PHARMACEUTICALS, INC.Restricted Stock Unit Agreement for Non-Employee Directors • November 9th, 2021 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations
Marinus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby grants restricted Stock Units (the “RSUs”) representing the right to receive shares of its common stock, par value $0.001 (the “Stock”), to the recipient (the “Grantee”) set forth on the Schedule to Restricted Unit Agreement for Non-Employee Directors attached hereto (the “Schedule), subject to the vesting and other conditions set forth below and in the Schedule. The terms and conditions of the RSUs are set forth in this Restricted Stock Unit Agreement and the Schedule (collectively, the “Agreement”), as well as in the Company’s 2014 Equity Incentive Plan (as it may be amended from time to time, the “Plan”). All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. COLLABORATION AGREEMENTCollaboration Agreement • November 9th, 2021 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • New York
This COLLABORATION AGREEMENT (this “Agreement”) is made as of July 30, 2021 (the “Effective Date”), by and between Marinus Pharmaceuticals, Inc. a corporation incorporated and existing under the laws of the State of Delaware (“Marinus”), having a principal place of business at 5 Radnor Corporate Center, 100 Matsonford Rd, Suite 500, Radnor, PA 19087, and Orion Corporation, a corporation incorporated and existing under the laws of Finland, business identity code 1999212-6 (“Licensee”), having a principal place of business at Orionintie 1, 02200 Espoo, Finland. Marinus and Licensee are referred to in this Agreement individually as a “Party” and collectively as the “Parties”.
MARINUS PHARMACEUTICALS, INC.Incentive Stock Option Agreement • November 9th, 2021 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations
Marinus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby grants an option (the “Option”) to purchase shares of its common stock, par value $0.001 (the “Stock”), to the recipient (the “Grantee”) set forth on the Schedule to Incentive Stock Option Agreement attached hereto (the “Schedule”), subject to the vesting and other conditions set forth below and in the Schedule. The terms and conditions of the Option are set forth in this Incentive Stock Option Agreement and the Schedule (collectively, the “Agreement”), as well as in the Company’s 2014 Equity Incentive Plan (as it may be amended from time to time, the “Plan”). All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.
